![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[81]
刘新泳 , 展鹏 and 康东伟.
Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Tra.
《Journal of Medicinal Chemistry》,
62,
1484,
2019.
-
[82]
刘新泳 , 展鹏 and 黄伯世.
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Bindi.
《Journal of Medicinal Chemistry》,
62,
2083,
2019.
-
[83]
展鹏 , 刘新泳 and 程锡强.
Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integr.
Expert Opinion on Therapeutic Patents,
27,
1277,
2017.
-
[84]
刘新泳 , 展鹏 and Zhang, Heng.
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-bas.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
130,
209,
2017.
-
[85]
刘新泳 , 康东伟 , 展鹏 and Liu, Zhaoqiang.
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
140,
383,
2017.
-
[86]
刘新泳 and 展鹏.
Strategies for the Discovery of Target-Specifific or Isoform-Selective Modulators.
Journal of Medicinal Chemistry,
2015.
-
[87]
展鹏 , 刘新泳 and Li, Xiao.
Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-gui.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
126,
190,
2017.
-
[88]
展鹏 , 刘新泳 and 汪昭.
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidin.
Chemical Biology & Drug Design,
92,
2009,
2018.
-
[89]
刘新泳 , 展鹏 and 张健.
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Vir.
Journal of Medicinal Chemistry,
61,
9976,
2018.
-
[90]
展鹏 , 刘新泳 and 鞠翰.
Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution.
Future Medicinal Chemistry,
11,
265,
2019.
-
[91]
展鹏 and 刘新泳.
Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candi.
《Journal of Medicinal Chemistry》,
62,
3251,
2019.
-
[92]
刘新泳 and 展鹏.
Privileged structure-derived design, synthesis and biological evaluation of novel DAPY analogues as .
2018.
-
[93]
刘新泳 and 展鹏.
First discovery of 5-hydroxypyrido[2,3-b]pyrazin-6(5H)-ones as HIV-1 ribonuclease H and integrase du.
2018.
-
[94]
刘新泳 and 展鹏.
Discovery of novel phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-.
2018.
-
[95]
刘新泳 , 康东伟 and 展鹏.
Development of a practical synthesis of etravirine via a microwave-promoted amination.
chemistry central Journal,
2018.
-
[96]
刘新泳 and 展鹏.
Design, synthesis and biological evaluation of oseltamivir derivatives targeting 430-cavity of influ.
2018.
-
[97]
刘新泳 , 康东伟 and 展鹏.
Identification of dihydrofuro[3,4-d]pyrimidine derivatives as novel HIV-1 NNRTIs with promising anti.
2018.
-
[98]
刘新泳 , 康东伟 and 展鹏.
The discovery of novel diarylpyri(mi) dine derivatives with high level activity against a wide varie.
Bioorganic & Medicinal Chemistry,
2018.
-
[99]
刘新泳 and 展鹏.
Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholines.
Med Chem Commun.,
2018.
-
[100]
刘新泳 , 展鹏 and 康东伟.
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influen.
J Med Chem.,
2018.
